Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma
- PMID: 12036886
- DOI: 10.1182/blood.v99.12.4540
Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma
Abstract
In vitro studies suggest that resistance to chemotherapy-induced apoptosis might explain poor response to therapy in fatal cases. Actual execution of apoptosis depends on proper functioning of effector caspases, particularly caspase 3, and on the expression levels of apoptosis-regulating proteins, including Bcl-2 and the recently identified granzyme B- specific protease inhibitor 9 (PI9). Thus, high levels of caspase 3 activation should reflect proper functioning of the apoptosis pathways, resulting in chemotherapy-sensitive neoplastic cells and a favorable prognosis. We tested this hypothesis by quantifying numbers of tumor cells positive for active caspase 3, Bcl-2, and PI9, respectively, in pretreatment biopsies of systemic anaplastic large cell lymphoma (ALCL) patients and by comparing these numbers with clinical outcome. Activation of caspase 3 in more than 5% of the tumor cells was strongly correlated with a highly favorable outcome. High numbers of Bcl-2- and PI9-positive tumor cells were found to predict unfavorable prognosis. This prognostic effect was strongly related to anaplastic lymphoma kinase (ALK) status: ALK-positive ALCL had significantly higher levels of active caspase 3, while high expression of the antiapoptotic proteins Bcl-2 and PI9 was almost completely restricted to ALK-negative cases. In conclusion, high numbers of active caspase 3-positive tumor cells predict a highly favorable prognosis in systemic ALCL patients. Poor prognosis is strongly related to high numbers of Bcl-2- and PI9-positive neoplastic cells. These data support the notion that a favorable response to chemotherapy depends on an intact apoptosis cascade. Moreover, these data indicate that differences in prognosis between ALK-positive and ALK-negative ALCL might be explained by differences in expression of apoptosis-inhibiting proteins.
Similar articles
-
ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.J Pathol. 2003 May;200(1):4-15. doi: 10.1002/path.1331. J Pathol. 2003. PMID: 12692835 Review.
-
High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome.Blood. 2002 Jul 1;100(1):36-42. doi: 10.1182/blood.v100.1.36. Blood. 2002. PMID: 12070005
-
Caspase-3 activation in systemic anaplastic large-cell lymphoma.Mod Pathol. 2004 Jan;17(1):109-16. doi: 10.1038/modpathol.3800039. Mod Pathol. 2004. PMID: 14657946
-
Intrinsic apoptotic pathway in anaplastic large cell lymphoma.Hum Pathol. 2006 Jul;37(7):874-82. doi: 10.1016/j.humpath.2006.02.020. Epub 2006 May 26. Hum Pathol. 2006. PMID: 16784988
-
Anaplastic large cell lymphoma, ALK-negative.Crit Rev Oncol Hematol. 2013 Feb;85(2):206-15. doi: 10.1016/j.critrevonc.2012.06.004. Epub 2012 Jul 11. Crit Rev Oncol Hematol. 2013. PMID: 22789917 Review.
Cited by
-
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors.Clin Cancer Res. 2018 Feb 15;24(4):744-752. doi: 10.1158/1078-0432.CCR-17-1590. Epub 2017 Nov 14. Clin Cancer Res. 2018. PMID: 29138343 Free PMC article. Clinical Trial.
-
Research progresses in the pathogenesis of anaplastic large cell lymphoma.Chin J Cancer. 2011 Jun;30(6):392-9. doi: 10.5732/cjc.010.10361. Chin J Cancer. 2011. PMID: 21627861 Free PMC article. Review.
-
Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.Mol Cancer. 2014 Aug 29;13:199. doi: 10.1186/1476-4598-13-199. Mol Cancer. 2014. PMID: 25168906 Free PMC article.
-
Radiolabelled apoptotic probe may be a vehicle for a novel multimodality radionuclide tumour therapy.Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1255-6. doi: 10.1007/s00259-014-2725-7. Epub 2014 Feb 25. Eur J Nucl Med Mol Imaging. 2014. PMID: 24566950 No abstract available.
-
Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients.J Hematol Oncol. 2012 Jul 7;5:38. doi: 10.1186/1756-8722-5-38. J Hematol Oncol. 2012. PMID: 22769020 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials